Answers are grounded in this paper and cite their sources.
In November 2002, a previously unknown severe acute respiratory syndrome (SARS) was observed in patients of the Guangdong Province, China (7). In March 2003, a new coronavirus (SARS-CoV) was associated with the SARS outbreak (2), and several full-genome sequences of SARS-CoV were obtained and compared (4). The family Coronaviridae comprises large, single, plus-stranded RNA viruses isolated from several species and previously known to cause common colds and diarrheal illnesses in humans (3). The emergence of such a novel, highly virulent pathogen warrants rapid investigation of its etiology and evolution to effectively control its impact on human health. In particular, estimating the rate of evolution of SARS-CoV would give an indication of how quickly the virus can potentially increase its genetic variability, which in turn has important implications for disease progression and drug and vaccine development.
No takes yet. Share an insight, caveat, or question.
Salemi et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: